Analysts at HSBC assumed coverage on shares of Align Technology (NASDAQ:ALGN – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm set a “buy” rating and a $450.00 price target on the medical equipment provider’s stock. HSBC’s target price indicates a potential upside of 21.58% from […]